Literature DB >> 24733

Effects of verapamil on excitation-contraction coupling in frog sartorius muscle.

A Y Bondi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 24733

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  10 in total

1.  Intravenous verapamil for tachyarrhythmia in Duchenne's muscular dystrophy.

Authors:  Y Ilan; M Hillman; R Oren
Journal:  Pediatr Cardiol       Date:  1990-07       Impact factor: 1.655

2.  Neuromuscular blocking action of verapamil in cats.

Authors:  B J Kraynack; N W Lawson; J Gintautas
Journal:  Can Anaesth Soc J       Date:  1983-05

3.  Studies on the calcium antagonistic action of tetrandrine: VII. Effects of tetrandrine on contractility of isolated rat uterus.

Authors:  D C Fang; W X Yao; J L Zhao; M X Jiang
Journal:  Acta Acad Med Wuhan       Date:  1984

4.  Differential effects of Ca antagonists on the noradrenaline release and contraction evoked by nerve stimulation in the presence of 4-aminopyridine.

Authors:  H Kato; Y Takata
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

5.  Calcium channels and intracellular calcium release are pharmacologically different in frog skeletal muscle.

Authors:  E W McCleskey
Journal:  J Physiol       Date:  1985-04       Impact factor: 5.182

6.  Effects of diltiazem and verapamil on responses to acetylcholine.

Authors:  R E Wachtel
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

7.  Effects of the calcium antagonist gallopamil (D600) upon excitation-contraction coupling in toe muscle fibres of the frog.

Authors:  D Berwe; G Gottschalk; H C Lüttgau
Journal:  J Physiol       Date:  1987-04       Impact factor: 5.182

8.  Possible mechanism of ciliary stimulation by extracellular ATP: involvement of calcium-dependent potassium channels and exogenous Ca2+.

Authors:  T Weiss; L Gheber; V Shoshan-Barmatz; Z Priel
Journal:  J Membr Biol       Date:  1992-05       Impact factor: 1.843

9.  Effects of verapamil on lipolysis due to dibutyryl cyclic AMP.

Authors:  H Goko; S Takashima; S Shimizu; S Kagawa; A Matsuoka
Journal:  Biochem J       Date:  1984-05-15       Impact factor: 3.857

10.  The effect of verapamil on the Ca2+-transporting and Ca2+-ATPase activity of isolated cardiac sarcolemmal preparations.

Authors:  J Mas-Oliva; W G Nayler
Journal:  Br J Pharmacol       Date:  1980-12       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.